An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia

Pharmaceutical Research

Volumn 19, Issue 11, 2002, Pages 1630-1635

  Veng Pederson, P ^a   Chapel, S ^a   Schmidt, P R L ^b   Al Huniti, N H ^a   Cook, R T ^b   Widness, J A ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Erythropoietin; Hemoglobin; Phlebotomy; Progenitor cells; Reticulocytes

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CELL KINETICS; CELL MATURATION; ERYTHROCYTE; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; NONHUMAN; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PHLEBOTOMY; PRIORITY JOURNAL; RETICULOCYTE; RETICULOCYTE COUNT; SHEEP;

ACUTE DISEASE; ANEMIA; ANIMALS; ERYTHROPOIETIN; HEMOGLOBINS; PHLEBOTOMY; RETICULOCYTES; SHEEP;

EID: 0036845839     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020797110836     Document Type: Article

References (21)

1. S. H. Chapel, P. Veng-Pedersen, R. L. Schmidt, and J. A. Widness. A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep. J. Pharmacol. Exp. Ther. 295:346-351 (2000).
2. J. A. Widness, R. L. Schmidt, P. Veng-Pedersen, N. Modi, and S. T. Sawyer. A sensitive and specific erythropoietin immunoprecipitation assay: Application to pharmacokinetic studies. J. Lab. Clin. Med. 119:285-294 (1992).
3. C. Peters, M. K. Georgieff, P. A. de Alarcon, R. T. Cook, L. F. Burmeister, L. S. Lowe, and J. A. Widness. Effect of chronic erythropoietin administration on plasma iron in newborn lambs. Biol. Neonate 70:218-228 (1996).
4. M. K. Georgieff, R. L. Schmidt, M. M. Mills, W. J. Radmer, and J. A. Widness. Fetal iron and cytochrome c status after intrauterine hypoxemia and erythropoietin administration. Am. J. Physiol. 262:R485-R491 (1992).
5. J. W. Adamson, B. Torok-Storb, and N. Lin. Analysis of erythropoiesis by erythroid colony formation in culture. Blood Cells 4:89-103 (1978).
6. M. C. Mackey and P. Dormer. Continuous maturation of proliferating erythroid precursors. Cell Tissue Kinet. 15:381-392 (1982).
7. P. Veng-Pedersen. Curve fitting and modelling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J. Pharmacokinet. Biopharm. 5:513-531 (1977).
8. M. F. Hutchinson and F. R. deHoog. Smoothing noise data with spline functions. Numer. Math. 47:99-106 (1985).
9. 51Cr-labeled red cells. Transfusion 39:156-162 (1999).
10. J. S. Kaufman, D. J. Reda, C. L. Fye, D. S. Goldfarb, W. G. Henderson, J. G. Kleinman, and C. A. Vaamonde. Subcutaneous compared with intravenous Epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients. N. Engl. J. Med. 339:578-583 (1998).
11. I. C. Macdougall, D. E. Roberts, G. A. Coles, and J. D. Williams. Clinical pharmacokinetics of Epoetin (recombinant human erythropoietin). Clin. Pharmacokinet. 20:99-113 (1991).
12. S. F. Lui, W. W. Chung, C. B. Leung, K. Chan, and K. N. Lai. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clin. Nephrol. 33:47-51 (1990).
13. T. Salmonson, B. G. Danielson, and B. Wikstrom. Pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br. J. Clin. Pharmacol. 29:709-713 (1990).
14. W. H. Yoon, S. J. Park, I. C. Kim, and M. G. Lee. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats. Res. Commun. Mol. Pathol. Pharmacol. 96:227-240 (1997).
15. A. Markham and H. M. Bryson. Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications. Drugs 49:232-254 (1995).
16. G. L. Wang and G. L. Semenza. General involvement of hypoxia-induced factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90:4304-4308 (1998).
17. K. Guillemin and M. A. Krasnow. The hypoxic response. Huffing and HITing. Cell 89:9-12 (1997).
18. C. A. Finch, L. A. Harker, and J. D. Cook. Kinetics of the formed elements of human blood. Blood 50:699-707 (1977).
19. E. Beutler, M. A. Lichtman, B. S. Coller, and T. J. Kipps. Williams Hematology, 5th ed. McGraw-Hill, New York (1995).
20. W. Krzyzanski, R. Ramakrishnan, and J. Jusko. Basic pharmacodynamic models for agents that alter production of natural cells. J. Pharmacokinet. Biopharm. 27:467-489 (2000).
21. H. Akaike. Automatic control: A new look at the statistical model identification. IEEE Trans. Control Theory 19:716-723 (1974).